Norris Medicines Ltd. logo

Norris Medicines Ltd. (NORRIS)

Market Open
11 Aug, 22:00
MSE MSE
16. 00
+0.65
+4.2345%
129.71M Market Cap
- P/E Ratio
- Div Yield
1,036 Volume
0 Eps
15.35
Previous Close
Add Transaction
Day Range
14.6 16
Year Range
12 19.63
Want to track NORRIS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NORRIS trading today higher at ₹16, an increase of 4.2345% from yesterday's close, completing a monthly increase of 7.3105% or ₹1.09. Over the past 12 months, NORRIS stock gained 9.589%.
NORRIS is not paying dividends to its shareholders.
The last earnings report, released on May 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Norris Medicines Ltd. has completed 1 stock splits, with the recent split occurring on Aug 22, 2013.
The company's stock is traded on one exchange.

NORRIS Chart

Norris Medicines Ltd. (NORRIS) FAQ

What is the stock price today?

The current price is ₹16.00.

On which exchange is it traded?

Norris Medicines Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is NORRIS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 129.71M.

Has Norris Medicines Ltd. ever had a stock split?

Norris Medicines Ltd. had 1 splits and the recent split was on Aug 22, 2013.

Norris Medicines Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Vimal Dhirendra Shah CEO
MSE Exchange
INE744C01029 ISIN
India Country
33 Employees
- Last Dividend
22 Aug 2013 Last Split
- IPO Date

Overview

Norris Medicines Limited is a distinguished entity in the Indian pharmaceutical sector, renowned for its dedication to the research and production of medical preparations. Founded in 1990 and headquartered in Ankleshwar, India, the company has carved a niche in the pharmaceutical industry by offering a wide array of medical products and services. With a strong presence in both the domestic and international markets, including exporting to Ukraine, Ghana, and other African countries, Norris Medicines Limited has established itself as a key player in the pharmaceutical manufacturing sector. The company is also recognized for its contract and loan license manufacturing services, catering to the needs of multinational and Indian pharma companies alike.

Products and Services

  • Antibiotic Products: These include a range of pharmaceuticals designed to combat bacterial infections, catering to various spectrums and classes of antibiotics.
  • Anti-inflammatory/Pain Management: Products in this category are formulated to reduce inflammation and manage pain. This includes non-steroidal anti-inflammatory drugs (NSAIDs) among others.
  • Anti-emetic Products: These medications are designed to prevent or alleviate nausea and vomiting, addressing different causes of these symptoms.
  • Nutrition: The nutritional range encompasses supplements and medicaments geared towards improving and maintaining general health and well-being.
  • Gastrointestinal: This segment includes products aimed at treating various gastrointestinal conditions, such as acid reflux, ulcers, and other digestive issues.
  • Cough/Cold Remedies: The company manufactures a variety of products to address the symptoms and causes of coughs and colds, including both over-the-counter and prescription options.
  • Skin and Allergy: Solutions for skin conditions and allergies are available, ranging from topical treatments to oral medications designed to treat a wide array of dermatological issues and allergic reactions.
  • Anti-malarial: These products are focused on the treatment and prevention of malaria, encompassing various therapeutic classes.
  • Diabetic and Cardiac: Norris Medicines offers products aimed at managing diabetes and cardiac conditions, highlighting the importance of these chronic conditions in their product lineup.
  • Gynecology: A range of products catered specifically towards women's health, addressing various gynecological conditions.
  • Dermatology: This includes treatments for skin disorders and diseases, with a focus on both therapeutic and aesthetic dermatology.
  • Dental: Dental care products designed to treat and manage dental and oral health conditions are part of the extensive portfolio.

In addition to these products, Norris Medicines Limited provides contract and loan license manufacturing services, offering its manufacturing expertise to multinational and Indian pharmaceutical companies. This allows the company to produce a vast range of pharmaceutical products under contract, adhering to strict quality standards and regulatory requirements.

Contact Information

Address: Plot No. 801/P
Phone: 91 26 4622 3462